The efficacy of dapagliflozin for type 1 diabetes: a meta-analysis of randomized controlled studies

INTRODUCTION: The efficacy of dapagliflozin for type 1 diabetes remains controversial. We conduct a systematic review and meta-analysis to explore the treatment efficacy of dapagliflozin versus placebo in patients with type 1 diabetes. METHODS: We have searched PubMed, EMbase, Web of science, EBSCO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jian, Zhao, Yanhong, Fan, Huihui, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Makerere Medical School 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356594/
https://www.ncbi.nlm.nih.gov/pubmed/34394274
http://dx.doi.org/10.4314/ahs.v21i1.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356594/
https://www.ncbi.nlm.nih.gov/pubmed/34394274
http://dx.doi.org/10.4314/ahs.v21i1.2

Ejemplares similares